Details of the Drug-Related molecule(s) Activity Atlas

General Information of Drug (ID: DMNLQHK)

Drug Name
Tanespimycin Drug Info
Synonyms
CNF-101; [(3S,5S,6R,7S,8E,10R,11S,12E,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate; [(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate; 17AAG, Tanespimycin, Geldanamycin, NSC330507, 17-(Allylamino)-17-demethoxygeldanamycin, CP 127374
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
6505803
ChEBI ID
CHEMBL64153
CAS Number
CAS 75747-14-7
TTD ID
D0SC2J

Molecule-level Activity Landscape of This Drug
Molecule Name Gene Name UniProt ID Type IC50 (nM) Details
Loading IC50 data...
Molecule Name Gene Name UniProt ID Type EC50 (nM) Details
Loading EC50 data...
Molecule Name Gene Name UniProt ID Type Kd (nM) Details
Loading Kd data...
Molecule Name Gene Name UniProt ID Type Ki (nM) Details
Loading Ki data...

Experimental Drug Sensitivity Data Across Cancer Cell Lines
Cell Line Related Disease IC50 (Log₂ µM) Original Dataset Details
Loading Cell Activity data...

Cytotoxic Activity Landscape of This Drug

Cell Line Disease Value (nM) ChEMBL Assay ID Details
Loading ChEMBL activity data...